No content results match your keyword.
Content
You have successfully logged out.
Not registered yet?
No product results match your keyword.
Products
Press Releases
Latest news about B. Braun
Here you will find all our recent press releases, media information, financial news as well as photos and contacts.
Fiscal year 2024: B. Braun continues to grow in a demanding environment
The B. Braun Group has expanded its business operations in a demanding environment: sales increased by 4.4 percent to 9.1 billion euros in the 2024 fiscal year. Profit before taxes improved primarily due to increased efficiency and optimized structures. The company has invested in modern technologies as well as research and development at its global sites.
Read more
Thursday, 5 December 2024
Jury rules in favor of B. Braun’s US subsidiaries
Since early November, a trial has been ongoing against certain subsidiaries of B. Braun in the USA. The case involved the allegation that ethylene oxide emissions from our sterilization process at our device manufacturing plant in Allentown, PA (USA) have caused personal injuries. Today the jury ruled in favor of B. Braun’s US subsidiaries and rejected all of the plaintiff’s claims.
Read moreB. Braun drives innovation in health care while
sales and profit improved
The B. Braun Group grew its business operations and successfully advanced its strategy in the 2023 fiscal year. Sales rose 3.0 percent to 8.8 billion euros (previous year: 8.5 billion euros) and profit before tax grew 15.3 percent.
Read more
Wednesday, 28 February 2024
B. Braun SE publishes policy statement on human rights and environmental due diligence in accordance with the German Supply Chain Due Diligence Act
On February 7, 2024, the Management Board of B. Braun SE adopted the "Policy Statement of Principles of B. Braun SE on Human Rights and Environmental Due Diligence".
Read moreB. Braun SE: Jean-Claude Dubacher appointed to the Executive Board
At its meeting on December 12, the Supervisory Board of B. Braun SE appointed Dr. Jean-Claude Dubacher as a member of the Executive Board of B. Braun SE effective April 1, 2024. He will assume responsibility for the B. Braun Avitum division and at the same time become Chairman of the Executive Board of B. Braun Avitum AG. He will take over both functions from Anna Maria Braun, who is currently responsible for the division on an interim basis alongside her role as CEO of B. Braun SE.
Read more
Thursday, 17 August 2023
B. Braun SE: Ingrun Alsleben appointed to the Executive Board
The Supervisory Board of B. Braun SE has appointed Mrs. Ingrun Alsleben as member of the Executive Board of B. Braun SE effective January 1, 2024. Mrs. Alsleben comes from the Bayer Group, where she was most recently responsible for the countries Turkey/Iran as CEO and CFO. As of April 1, 2024, Ingrun Alsleben is to take over the position of Chief Financial Officer from Dr. Annette Beller, who will retire.
Read moreAesculap Academy is awarded global accreditation by the Royal College of Surgeons of England
The Aesculap Academy education portfolio and global centres have been awarded global accreditation by the Royal College of Surgeons of England (RCS England) for three years until March 2026.
Read more
Friday, March 23, 2023
B. Braun closes 2022 fiscal year with sales growth – result burdened
The B. Braun Group recorded 8.5 billion euros in sales in FY 2022 (previous year: 7.9 billion euros). Adjusted for currency effects, this is an increase of 3.6 percent. The result was burdened by high expenses to maintain supply availability as well as one-off effects.
Read moreAesculap AG becomes sole shareholder of Schölly Fiberoptic GmbH from January 1, 2023
Schölly Fiberoptic GmbH is once again undergoing a reorganization of its shareholding structure. Aesculap AG will become the sole shareholder on January 1, 2023 and will thus take over the entire company shares of the family business.
Read more
B. Braun presents its engagement in Africa at the Citizens’ Festival of the Federal President 2022
Protecting and improving the health of people around the world is the
vision that has driven the medical technology company B. Braun,
based in Melsungen, Germany, for 183 years.
B. Braun is deeply saddened by the death of Michael Ungethüm - a unique man of business, science and culture
Prof. Dr. Dr. h.c. Michael Ungethüm passed away on August 4 at the age of 78. He was Chairman of the Management Board of Aesculap AG for 19 years and a member and Vice Chairman of the Management Board of what is now B. Braun SE from 2000 to 2009.
Read more
Changes in the Aesculap Management Board
B. Braun's surgical division Aesculap has a new Management Board. After Dr. Jens von Lackum had already taken over as Chairman of the Management Board effective April 1st, 2022, the Aesculap Supervisory Board yesterday appointed two new members to the Management Board: Prof. Dr. Holger Reinecke and Andreas Hahn will join the board on July 1st, 2022.
Read moreAesculap secures distribution rights for digital surgical microscope
With the conclusion of a new distribution agreement, B. Braun surgery division Aesculap has strengthened its long-term partnership with True Digital Surgery, a Californian company that is an expert in robotically controlled 3D digital visualization.
Read more
Strategic decision: B. Braun divests Colombian provider business
B. Braun has decided to sell its provider and hospital services business in Colombia. Effective March 16, the local company Grupo Uros will take over all dialysis centers including their approx. 230 clinical employees. B. Braun has provided high-quality dialysis care to up to 2,000 patients over the last eight years.
Read moreFiscal year 2021:
B. Braun increases sales in a challenging environment
The B. Braun Group increased its sales in FY 2021 by 5.8 percent year over year, to €7,859.9 million (previous year: €7,426.3 million). Thanks to extraordinary efforts, B. Braun was able to ensure delivery capability to its customers, even with significant added pressure on the supply chains.
Read more
Changes in the B. Braun SE Executive Board: Dr Meinrad Lugan moves to the Executive Board of the family holding company
Effective April 1, 2022, Dr Meinrad Lugan will change from the B. Braun SE Executive Board to the Executive Board of affiliated company B. Braun Familienholding Verwaltungs SE at his own request as part of a planned generational change. Dr. Lugan is thus giving up his responsibilities for the Hospital Care division.
Read moreB. Braun acquires Intermedt Medizin & Technik GmbH, a specialist in the preparation of dialysis concentrates
With the full integration of Intermedt Medizin & Technik GmbH into the Group, B. Braun has completed the extensive product portfolio of its B. Braun Avitum division as a systems provider for extracorporeal blood treatment (dialysis).
Read more
B. Braun expands footprint in Vietnam with ground-breaking of new factory
B. Braun celebrated the official ground-breaking of a state-of-the-art Haemodialysis Concentrate Factory in the Thanh Oai Industrial Complex in Hanoi, Vietnam on January 10, 2022.
Read moreDr Jens von Lackum appointed to the Management Board of B. Braun SE
At its meeting on December 7th 2021, the Supervisory Board of B. Braun SE appointed Dr Jens von Lackum as deputy member of the Management Board of B. Braun SE.
Read more
Your contact to the Media Relations Team
Christine Bossak
Vice President Group Internal & External Communications
Take part in our customer survey
Your feedback matters! Participate in our customer survey to help us enhance our website, products and services. Thank you for your support!